Novartis forges UC Berkeley pact, sees drug hopefuls in three years

ZURICH (Reuters) - Novartis's NOVN.S research head expects an alliance with a University of California chemistry lab to produce drug candidates within three years as the Swiss company accelerates its hunt for new medicines.